Please login to the form below
Article 50
This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.
UK heart deaths rise for first time in 50 years
50 years, warns a new report from charity the British Heart Foundation.
Latest news
-
Brexit "having impact on EU drug development”
There’s little sign that the Brexit pressure will let up for a few months at least, now that a delay to the Article 50 date has been set to 31
-
No-deal risk recedes, but new Brexit delay adds to uncertainty
With the extension of Article 50, we will work with Government to consider how best to prepare and review whether current plans for a no deal Brexit are still appropriate.”.
-
Pharma asked to consider 5 things as no-deal Brexit looms again
If ‘no-deal’ were rejected, Article 50 would be revoked and an inquiry set up to establish whether any form of Brexit could command a majority.
-
UK business: Brexit deadlock causing “frustration and anger”
B ‘managed no-deal’ option with an extended transition period; accepting a no-deal exit on 12 April; revoking Article 50 and halting Brexit; and Common Market 2.0 – also known ... When it comes to any further extension to Article 50, which would be
-
Pharma fears “lack of focus” on no-deal Brexit preparations
The comments came ahead of the pivotal deliberations in Brussels yesterday where the Council agreed to extend the Article 50 deadline from 29 March to 22 May – assuming MPs approved Prime ... This came even as a petition to revoke Article 50 and cancel
More from news
Approximately 0 fully matching, plus 33 partially matching documents found.
Latest Intelligence
-
Leave or remain? Winning the employee referendum
killer question: ‘Should I stay or should I go?’ Our decision to trigger the employee equivalent of Article 50 will normally be influenced by our experiences with our current employer. ... We all know you. can’t run a business on 50% turnover, but
-
The Patient Safety Challenge
The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme
-
Macron, Merkel and May: implications of the 2017 elections for the life science industry
50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’ transition period
-
Brexit: the facts (and the alternative facts)
How Brexit affects pharma. The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.
-
Brexit: Implications for the pharma industry
Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report
The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.
-
50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need. ... That's why we have created this 50-question checklist to help you deliver an exceptional brand
-
Random42 Named in Alantra’s Pharma Fast 50.
The London based scientific communication studio have been named in this year’s Pharma Fast 50, an annual ranking of the UK’s fastest-growing companies within the pharmaceutical industry. ... For more on the Pharma Fast 50 read the full article: .
-
Brexit and Pharma: A match made in hell.
Countless other challenges remain, but we need to move forward, especially now that we have witnessed the triggering of article 50.
-
Research Partnership has been ranked in the Pharma Times Pharma Fast 50
Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research Partnership
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- My MS journey: one patient's search for innovation
- David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
- Biotech profile: Tom Evans, CEO, Vaccitech.
- Can UK company be first to develop a universal flu vaccine?...
- The social dilemma: is it time for pharma to join the party?
- Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
Quick links
Infographics
